ISU Abxis Co., Ltd. (KOSDAQ:086890)
South Korea · Delayed Price · Currency is KRW 4,135.00
-170.00 (-3.95%)
At close: May 15, 2026
ISU Abxis Market Cap
ISU Abxis has a market cap or net worth of 168.58 billion as of May 15, 2026. Its market cap has decreased by -10.44% in one year.
Market Cap
168.58B
Enterprise Value
175.13B
Revenue
56.67B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,135.00
Market Cap Chart
Since February 3, 2009, ISU Abxis's market cap has increased from 55.97B to 168.58B, an increase of 201.22%. That is a compound annual growth rate of 6.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 175.51B | -14.69% |
| Dec 30, 2025 | 205.73B | 28.77% |
| Dec 30, 2024 | 159.77B | -23.70% |
| Dec 28, 2023 | 209.40B | 9.75% |
| Dec 29, 2022 | 190.80B | -34.58% |
| Dec 30, 2021 | 291.68B | 43.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 258.62B |
| Bio Solution | 247.72B |
| ViGenCell | 245.99B |
| ABION | 193.27B |
| Ensol Biosciences | 176.10B |
| CORESTEMCHEMON | 166.13B |
| Prestige Biologics | 163.28B |
| QuadMedicine | 131.13B |